| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 3961714 | Journal of Minimally Invasive Gynecology | 2016 | 23 Pages |
Abstract
Women have different risk tolerances. Most women would be willing to take the 1 in 350 (0.3%) risk of undiagnosed sarcoma spread to benefit from MIS approaches. FDA warnings may have unintended consequences by limiting the acceptable medical choices available for patients.
Related Topics
Health Sciences
Medicine and Dentistry
Obstetrics, Gynecology and Women's Health
Authors
Leslie MD, Patricia E. MD, CM, LLM,